Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Foamix Pharmaceuticals Ltd. | exhibit_32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Foamix Pharmaceuticals Ltd. | exhibit_32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Foamix Pharmaceuticals Ltd. | exhibit_31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Foamix Pharmaceuticals Ltd. | exhibit_31-1.htm |
| EX-10.8 - EXHIBIT 10.8 - Foamix Pharmaceuticals Ltd. | exhibit_10-8.htm |
| EX-10.7 - EXHIBIT 10.7 - Foamix Pharmaceuticals Ltd. | exhibit_10-7.htm |
| EX-10.6 - EXHIBIT 10.6 - Foamix Pharmaceuticals Ltd. | exhibit_10-6.htm |
| 10-K/A - 10-K/A - Foamix Pharmaceuticals Ltd. | zk1821314.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-222155) of Foamix Pharmaceuticals Ltd. of our report dated February 27, 2018 relating to the financial statements, which appears in this Amendment No. 1 to Form 10‑K/A.
|
Tel-Aviv, Israel
|
/s/ Kesselman & Kesselman
|
|
March 1, 2018
|
Certified Public Accountants (Isr.)
|
|
A member firm of PricewaterhouseCoopers International Limited
|
Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 6812508, Israel,
P.O Box 50005 Tel-Aviv 6150001 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il